Neutralization escape of emerging subvariants XBB.1.5/1.9.1 and XBB.2.3 from current therapeutic monoclonal antibodies

J Med Virol. 2023 Sep;95(9):e29074. doi: 10.1002/jmv.29074.

Authors

De Hoe Chye¹, Charmaine W Y Chew², He Ping Yeo², Paul A Tambyah³, Barnaby E Young^{2

4

5}, Gladys G Y Tan¹, Boon Huan Tan^{1

5}, Shawn Vasoo^{2

4

5}, Conrad E Z Chan^{1

2}

Affiliations

¹ DSO National Laboratories, Defence Medical and Environmental Research Institute, Singapore, Singapore.
² National Centre for Infectious Diseases, Singapore, Singapore.
³ Department of Medicine, Infectious Diseases Translational Research Program, Division of Infectious Diseases, National University Hospital, National University of Singapore, Singapore, Singapore.
⁴ Tan Tock Seng Hospital, Singapore, Singapore.
⁵ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

PMID: 37665160
DOI: 10.1002/jmv.29074

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

Grants and funding

Ministry of Health -Singapore